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Dear Editor,
According to the European registries, 24% of the pedi-
atric and 38% of the adult patients had an unspecifi ed 
or unknown primary kidney disease (1). At least some 
of these patients suff er from unrecognized rare dis-
ease. Rare diseases have been defi ned based on a prev-
alence of less than 5 in 10.000 people (2). Information 
on rare diseases and orphan drugs may be found on 
Orphanet which comprises >6700 rare diseases (3).
Knowledge of the primary cause of a disease is essen-
tial for adequate classifi cation, prognosis, and most 
importantly, for the treatment, while it may determine 
the type of transplantation which in some diseases 
may require simultaneous multiorgan transplantation.
Montenegro is a small country in the South-Eastern 
Europe with population of 620.000. Country is char-
acterized by diverse landscape with isolated commu-
nities especially in the highlands. Currently, 232 pa-
tients replace their renal function with dialysis and 
127 patients have functioning renal allograft , giving 
the prevalence of renal replacement therapy of 217 
pmp. Renal transplant program has been established 
in Montenegro in September 2012 in collaboration 
with the Croatian transplant team. Since that time, 45 
transplantations were performed, two of them from 
deceased donors, while 82 patients who received kid-
neys in foreign countries have been followed at our 
institution.
Of adult renal transplant recipients who received renal 
allograft , 53 patients have unknown primary kidney 
disease (41.7 %). Of patients with established diag-
nosis, four had Alport disease, three juvenile neph-
ronopthisis, two Dent’s disease, two Balkan endemic 
nephropathy, while C1q nephropathy, Fancony syn-
drome, De George syndrome and hemolytic-uremic 
syndrome were diagnosed in one patient each. Auto-
somal dominant polycystic kidney disease was cause 
of end-stage renal failure in 6 patients.
Of patients who are waiting for renal transplantation 
one patient has Jeune syndrome, one had Alport dis-
ease and one has been diagnosed with primary hyper-
oxaluria aft er ten years of hemodialysis. Six patients 
on the waiting list have ADPKD. Additionally, family 
clustering is present in four families with two to 7 in-
volved relatives, but none of them had diagnostic eval-
uation.
Rare diseases (without ADPKD) contributed 11.8 % 
to the prevalence of RRT in our patients. However, 
the number of patients with rare diseases as cause of 
end-stage renal disease is most likely underestimat-
ed, while many of our patients had unknown primary 
kidney disease which at least in some of them may be 
an undiagnosed rare disease. Additionally, many of 
them have family clustering of kidney diseases. Th is 
is in line with fi ndings of Quaglia et al. Out of 278 
patients with causal nephropathy, their group found 
rare genetic disorders in 12 patients (4.32%) (4). If we 
include ADPKD which is listed in Orphanet database 
(3), patients with rare diseases comprise 16.5 % of our 
renal transplant population.
Cardinal problems in our practice are late referral to 
nephrologist and limited options for diagnostic eval-
uation. Majority of patients had no biopsy, and any 
specifi c investigation should be send abroad to Euro-
pean laboratories. Better education of both nephrolo-
gists and non-nephrologists to recognize the clinical 
features of rare kidney diseases, and timely referral of 
suspected patients to expert centers are essential to 
promote awareness of rare kidney diseases. 
In conclusion, an unexpectedly high prevalence of 
rare genetic disorders was found in our cohort of renal 
transplant recipients. Th is number is likely underes-
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timated since many patients have unknown primary 
kidney disease. Earlier referral to nephrologists and 
comprehensive diagnostic evaluation may improve 
diagnosis and treatment of patients with rare diseases 
which aff ect kidneys.
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